Theranos plans to offer investors shares in the company in exchange for them not filing lawsuits against the embattled blood-testing company. WSJ's Christopher Weaver has exclusive details on Lunch Break. Photo: Reuters

Theranos plans to offer investors shares in the company in exchange for them not filing lawsuits against the embattled blood-testing company. WSJ's Christopher Weaver has exclusive details on Lunch Break. Photo: Reuters

Theranos Inc. plans to give additional shares to investors who pledge not to sue the battered blood-testing company or Elizabeth Holmes, its founder and chief executive, people familiar with the matter said.

The deal includes investors who participated in Theranos’s latest funding rounds, which ended in 2015 and brought in more than $600 million. Those investors could get about two additional shares for each share they bought, one of...|||

A deal approved by Theranos’s board would give investors who pledge not to sue the battered blood-testing company some shares from founder Elizabeth Holmes’s stake.